Increased plasma levels of homocysteine and other thiol compounds in rheumatoid arthritis women
- 1 February 1999
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 32 (1) , 65-70
- https://doi.org/10.1016/s0009-9120(98)00093-9
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Reduced, Oxidized and Protein-Bound Forms of Homocysteine and Other Aminothiols in Plasma Comprise the Redox Thiol Status—A Possible Element of the Extracellular Antioxidant Defense SystemJournal of Nutrition, 1996
- Hyperhomocysteinemia as a Risk Factor for Deep-Vein ThrombosisNew England Journal of Medicine, 1996
- Coexistence of Hereditary Homocystinuria and Factor V Leiden — Effect on ThrombosisNew England Journal of Medicine, 1996
- Vitamin Requirements for the Treatment of Hyperhomocysteinemia in HumansJournal of Nutrition, 1994
- Sulfhydryl compounds influence immunoreactivity, structure and functional aspects of lipoprotein (a)Thrombosis Research, 1994
- Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism.Proceedings of the National Academy of Sciences, 1992
- Endothelium-Derived Relaxing Factor Modulates the Atherothrombogenic Effects of HomocysteineJournal of Cardiovascular Pharmacology, 1992
- Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factorsEuropean Journal of Clinical Investigation, 1992
- Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.Stroke, 1990
- Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.Journal of Clinical Investigation, 1986